Lowenstein Sandler represented Hildred Capital in the transaction. Hildred Capital raised $750 million for its continuation fund to extend its ownership of two of its portfolio companies, Hyland’s...
Hildred Capital’s $750 Million Continuation Fund
ZMC’s Acquisition of InProduction
Willkie Farr & Gallagher LLP acted as legal advisor to InProduction, Lowenstein Sandler LLP acted as legal advisor to ZMC, while Latham & Watkins LLP represented...
Crown Laboratories’ Acquisition of Eclipse MedCorp’s Assets
Lowenstein Sandler represented Crown Laboratories in the transaction. Crown Laboratories, Inc. (“Crown”), a leading, fully integrated global skincare company, announced its agreement with Eclipse MedCorp LLC,...
Crown Laboratories’ Acquisition of StriVectin
Lowenstein advised Hildred Capital Management and Crown Laboratories on the deal, while Gibson, Dunn & Crutcher advised StriVectin and L Catterton. Hildred Capital Management (Hildred) and...